Daniel Loeb started to build up the position in PDL Biopharma in Q2 2006 and continued to invest until Q2 2007. Since then they sold 11.4M shares. The investor completely sold their stake between Q3 2007 and Q4 2007.
Avg closing price
Price range
Sold -11.3M shares
Q4 2007
Avg closing price
$18.17
Price range
$15.44
-
$22.10
Sold 0.9% shares (-100k shares)
Q3 2007
Avg closing price
$21.02
Price range
$17.58
-
$24.56
Increased shares by 34.9% (+2.95M shares)
Q2 2007
Avg closing price
$23.33
Price range
$20.17
-
$25.90
Increased shares by 157.6% (+5.17M shares)
Q1 2007
Avg closing price
$18.74
Price range
$17.08
-
$20.61
Increased shares by 42.6% (+980k shares)
Q4 2006
Avg closing price
$18.83
Price range
$18.83
-
$18.83
Increased shares by 1433.3% (+2.15M shares)
Q3 2006